WILMINGTON, DE — Incyte Corp. (NASDAQ: INCY) will outline upcoming pipeline updates and strategic priorities at two major healthcare investor conferences in early December.
Executives are scheduled to present at Citi’s 2025 Global Healthcare Conference on Dec. 2 at 11:15 a.m. EST, followed by the 8th Annual Evercore Healthcare Conference on Dec. 3 at 1:20 p.m. EST. Both presentations will be webcast live at Investor.Incyte.com and available for replay for 30 days.
The biopharmaceutical company, headquartered in Wilmington and active in North America, Europe, and Asia, continues to expand its portfolio of first-in-class medicines in oncology and autoimmune disease. Incyte says its mission, “Solve On.,” reflects a focus on advancing therapies for patients with unmet medical needs through internal discovery, clinical development, and commercialization.
Upcoming investor discussions are expected to highlight the company’s late-stage programs, recent regulatory milestones, and market opportunities across its core therapeutic areas. Investors will be watching closely as Incyte navigates a competitive landscape and advances a pipeline aimed at sustaining long-term growth.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.